| Primary |
| Diabetes Mellitus |
23.0% |
| Type 2 Diabetes Mellitus |
18.0% |
| Product Used For Unknown Indication |
12.9% |
| Hypertension |
10.1% |
| Type 1 Diabetes Mellitus |
7.9% |
| Chronic Obstructive Pulmonary Disease |
6.5% |
| Hypothyroidism |
2.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.9% |
| Coronary Artery Disease |
2.2% |
| Blood Pressure Abnormal |
1.4% |
| Dementia |
1.4% |
| Heart Valve Incompetence |
1.4% |
| Hyperlipidaemia |
1.4% |
| Insulin Resistance |
1.4% |
| Osteoporosis Prophylaxis |
1.4% |
| Pain |
1.4% |
| Pancreatogenous Diabetes |
1.4% |
| Asthma |
0.7% |
| Atrial Fibrillation |
0.7% |
| Blood Glucose Abnormal |
0.7% |
|
| Wrong Technique In Drug Usage Process |
25.0% |
| Hypoglycaemia |
16.7% |
| Completed Suicide |
6.3% |
| Blindness Unilateral |
4.2% |
| Diabetic Complication |
4.2% |
| Drug Ineffective |
4.2% |
| Incorrect Dose Administered |
4.2% |
| Intentional Drug Misuse |
4.2% |
| Loss Of Consciousness |
4.2% |
| No Adverse Event |
4.2% |
| Vision Blurred |
4.2% |
| Bacteraemia |
2.1% |
| Blood Pressure Increased |
2.1% |
| Death |
2.1% |
| Dementia |
2.1% |
| Diabetic Coma |
2.1% |
| Dyspnoea |
2.1% |
| Incorrect Product Storage |
2.1% |
| Memory Impairment |
2.1% |
| Mobility Decreased |
2.1% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
21.7% |
| Diabetes Mellitus |
14.3% |
| Type 1 Diabetes Mellitus |
9.4% |
| Supplementation Therapy |
7.0% |
| Product Used For Unknown Indication |
6.8% |
| Hypertension |
6.2% |
| Sedation |
4.7% |
| Pain |
4.5% |
| Pancreatitis |
4.0% |
| Drug Exposure During Pregnancy |
2.8% |
| Thrombosis Prophylaxis |
2.6% |
| Prophylaxis |
2.3% |
| Polyuria |
2.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.1% |
| Antibiotic Level |
1.9% |
| Constipation |
1.7% |
| Insulin Resistance |
1.7% |
| Pyrexia |
1.7% |
| Anaesthesia |
1.3% |
| Epilepsy |
1.3% |
|
| Toxic Epidermal Necrolysis |
11.8% |
| Hypoglycaemia |
7.4% |
| Haematocrit Decreased |
5.9% |
| Renal Failure Acute |
5.9% |
| Sepsis |
5.9% |
| Threatened Labour |
5.9% |
| Underdose |
5.9% |
| Gastroenteritis Cryptosporidial |
4.4% |
| Hyperglycaemia |
4.4% |
| Myocardial Infarction |
4.4% |
| Off Label Use |
4.4% |
| Optic Nerve Disorder |
4.4% |
| Pancreatitis |
4.4% |
| Skin Discolouration |
4.4% |
| Vision Blurred |
4.4% |
| Wrong Technique In Drug Usage Process |
4.4% |
| Bacteraemia |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Drug Ineffective |
2.9% |
| Multi-organ Failure |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.7% |
| Drug Use For Unknown Indication |
23.0% |
| Diabetes Mellitus |
11.8% |
| Hypertension |
8.3% |
| Prophylaxis |
5.9% |
| Hiv Infection |
4.4% |
| Type 2 Diabetes Mellitus |
3.2% |
| Antifungal Prophylaxis |
2.3% |
| Rheumatoid Arthritis |
2.2% |
| Aplastic Anaemia |
1.9% |
| Myocardial Infarction |
1.8% |
| Graft Versus Host Disease |
1.5% |
| Insomnia |
1.4% |
| Premedication |
1.4% |
| Infection Prophylaxis |
1.4% |
| Schizophrenia |
1.3% |
| Supportive Care |
1.3% |
| Constipation |
1.1% |
| Prophylaxis Against Graft Versus Host Disease |
1.1% |
| Non-small Cell Lung Cancer |
1.1% |
|
| Myocardial Infarction |
10.3% |
| Vomiting |
9.5% |
| Renal Impairment |
5.5% |
| Subarachnoid Haemorrhage |
5.5% |
| Pyrexia |
5.1% |
| Renal Failure |
5.1% |
| Somnolence |
4.8% |
| Urinary Tract Infection |
4.8% |
| Urine Colour Abnormal |
4.8% |
| Weight Decreased |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
| Angina Pectoris |
4.4% |
| Pain |
4.4% |
| Stevens-johnson Syndrome |
4.4% |
| Blood Glucose Increased |
3.7% |
| Cerebral Infarction |
3.7% |
| Hypoglycaemia |
3.7% |
| Loss Of Consciousness |
3.7% |
| Nausea |
3.7% |
| Renal Failure Acute |
3.7% |
|
| Interacting |
| Diabetic Foot |
50.0% |
| Type 1 Diabetes Mellitus |
50.0% |
|
|
